Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:12 pm Sale | 13G | Entrada Therapeutics Inc. TRDA | ROCHE FINANCE LTD | 2,744,120 8.200% | -69,405 (-2.47%) | View |
| 2023-11-07 5:16 pm Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | ROCHE FINANCE LTD | 11,025,941 15.350% | 7,933,601 (+256.56%) | View |
| 2023-02-13 4:52 pm Sale | 13G | ELOXX PHARMACEUTICALS INC ELOX | ROCHE FINANCE LTD | 1,893 0.100% | -4,997,043 (-99.96%) | View |
| 2023-02-13 4:49 pm Unchanged | 13G | JASPER THERAPEUTICS INC NE JSPR | ROCHE FINANCE LTD | 4,624,606 4.200% | 0 (Unchanged) | View |
| 2022-02-14 06:20 am Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | ROCHE FINANCE LTD | 72,612 1.100% | 72,612 (New Position) | View |
| 2022-02-14 06:19 am Sale | 13G | Vaxcyte Inc. PCVX | ROCHE FINANCE LTD | 2,334,113 4.400% | -253,641 (-9.80%) | View |
| 2022-02-14 06:19 am Purchase | 13G | Entrada Therapeutics Inc. TRDA | ROCHE FINANCE LTD | 2,813,525 9.000% | 2,813,525 (New Position) | View |
| 2022-02-14 06:18 am Sale | 13G | ALLAKOS INC ALLK | ROCHE FINANCE LTD | 2,629,157 4.800% | -1,916,566 (-42.16%) | View |
| 2022-02-14 06:18 am Purchase | 13G | ELOXX PHARMACEUTICALS INC ELOX | ROCHE FINANCE LTD | 4,998,936 5.800% | 2,466,666 (+97.41%) | View |
| 2021-10-04 08:54 am Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | ROCHE FINANCE LTD | 4,624,606 12.700% | 4,624,606 (New Position) | View |
| 2021-06-14 4:01 pm Purchase | 13G | ELOXX PHARMACEUTICALS INC ELOX | ROCHE FINANCE LTD | 2,532,270 5.300% | 2,532,270 (New Position) | View |
| 2021-03-02 4:15 pm Sale | 13G | Senseonics Holdings Inc. SENS | ROCHE FINANCE LTD | 17,523,209 4.700% | -10,822,066 (-38.18%) | View |
| 2021-02-16 07:03 am Purchase | 13G | ALLAKOS INC ALLK | ROCHE FINANCE LTD | 4,545,723 9.300% | 1,766,566 (+63.56%) | View |
| 2021-02-16 07:03 am Purchase | 13G | ALIGOS THERAPEUTICS INC NE ALGS | ROCHE FINANCE LTD | 3,092,340 8.100% | 3,092,340 (New Position) | View |
| 2021-02-16 07:02 am Purchase | 13G | Pandion Therapeutics Inc. PAND | ROCHE FINANCE LTD | 3,086,084 10.500% | 3,086,084 (New Position) | View |
| 2021-02-16 07:02 am Purchase | 13G | Vaxcyte Inc. PCVX | ROCHE FINANCE LTD | 2,587,754 5.100% | 2,587,754 (New Position) | View |
| 2021-02-16 07:02 am Unchanged | 13G | TEMPEST THERAPEUTICS INC TPST | ROCHE FINANCE LTD | 1,089,180 5.700% | 0 (Unchanged) | View |
| 2021-02-16 07:01 am Purchase | 13G | ALLAKOS INC ALLK | ROCHE FINANCE LTD | 2,779,157 5.300% | 2,779,157 (New Position) | View |
| 2021-02-16 07:01 am Purchase | 13G | Senseonics Holdings Inc. SENS | ROCHE FINANCE LTD | 28,345,275 11.500% | 28,345,275 (New Position) | View |
| 2020-03-17 09:08 am Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | ROCHE FINANCE LTD | 1,089,180 6.200% | 333,333 (+44.10%) | View |